Cargando…
Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
BACKGROUND: Chronic refractory angina is a challenging clinical problem with limited treatment options. The results of early cardiovascular stem cell trials using ABMMC have been promising but have utilized intracoronary or intramyocardial delivery. The goal of the study was to evaluate the safety a...
Autores principales: | Tuma, Jorge, Fernández-Viña, Roberto, Carrasco, Antonio, Castillo, Jorge, Cruz, Carlos, Carrillo, Alvaro, Ercilla, Jose, Yarleque, Carlos, Cunza, Jaime, Henry, Timothy D, Patel, Amit N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215661/ https://www.ncbi.nlm.nih.gov/pubmed/22029669 http://dx.doi.org/10.1186/1479-5876-9-183 |
Ejemplares similares
-
The Coronary Sinus Reducer for refractory angina
por: Damman, P., et al.
Publicado: (2021) -
The coronary sinus reducer for the treatment of refractory angina
por: Paz, Y., et al.
Publicado: (2016) -
Coronary sinus intervention for the treatment of refractory angina pectoris
por: Paz, Yoav, et al.
Publicado: (2011) -
Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
por: Mao, Hong, et al.
Publicado: (2019) -
Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction
por: Bieri, Mark, et al.
Publicado: (2020)